A rapidly aging population, rising medical costs worldwide, technology improvements, and government spending on healthcare infrastructure are all expected to contribute to the pharmaceutical industry's substantial expansion.
Given the industry’s long-term growth prospects, investors could consider buying fundamentally strong pharma stocks Eli Lilly and Company (LLY), Teva Pharmaceutical Industries Limited (TEVA), and Johnson & Johnson (JNJ).
